Search results for: 'Preferred Destination for Early Phase Clinical Trials'

This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature o...

19 Apr 2017  |  Asia Pacific  |  Market Research

Global CRO Market, Forecast to 2021

The Global CRO Market to Reach $64.58 Billion by 2021

Infographics

×

The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...

The lighter-than-air (LTA) and heavier-than-air (HTA) high-altitude pseudo satellite (HAPS) projects have had a long period of gestation, starting in the 1970s. Technological challenges, especially solar panel efficiency and battery density, have held the market back. The recent closing of the Google Loon project has raised questions on the feasibi...

As part of Frost & Sullivan’s seven-nation Voice of the Enterprise Security Customer research survey, this cut of the data presents a detailed overview of the key trends, drivers, and preferences that shape European organizations’ cybersecurity strategies. Structured around eight main cybersecurity solution areas, the report provides specific insig...

The commercial drone market in Australia, while at a nascent stage, has seen a surge of activity in recent years, particularly in service provider businesses. Drone applications are emerging in various sectors such as agriculture, mining, oil and gas (O&G), construction, utilities, and environmental conservation. Technological advancements are ma...

The Transformational Health team at Frost & Sullivan provides critical insights into the US clinical chemistry and immunoassay industry, highlighting the recent activities, key growth opportunities, and trends that are shaping the industry. The already dynamic in vitro diagnostics landscape in the United States was affected even more by the recen...

This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing gove...

Declining diesel share gives rise to newer opportunities for electric vehicles. Understanding consumer needs becomes quintessential toward driving future mobility developments. This research focuses on consumer needs and their willingness to pay for various powertrain features and electric vehicles. The respondents were questioned based on numerous...

15 Oct 2024  |  Global  |  Technology Research

Emerging Non-opioid Treatments for Pain Management

Advances in Non-opioid Therapies for Neuropathic, Migraine, and Cancer Pain Management Unlock New Growth Opportunities

Infographics

×

The analysis explores cutting-edge advancements in non-opioid medications by delving into their mechanisms of action at a molecular scale, scrutinizing results from current clinical research initiatives, and appraising preparedness for and plausibility of regulatory approval. The considerations aim to highlight how these treatments may offer viable...